Skin Tools

No. Skin tools at DDC are educational triage aids that produce routing outputs based on patient-supplied inputs. They cannot replace examination, history-taking, sometimes imaging, and clinical judgement applied to the specific patient. A diagnosis is more than a score on a self-administered scorecard; it depends on what the dermatologist actually observes alongside the broader picture. Tools support the consultation by helping patients arrive with a clearer picture of their concern; they do not replace the consultation itself. Patients who treat tool outputs as diagnoses and self-treat from them generally make worse decisions than patients who use the tools as the routing aids they are designed to be.

Most patients benefit from starting with the broad routing tools — the Fitzpatrick skin type quiz or the skin type analyzer — because skin type is a baseline that affects nearly every subsequent decision. From there, patients move to concern-specific tools (acne severity, pigmentation type finder, mole risk screener) and then to procedural-readiness aids if a procedural decision is being considered. The Featured pages above lay out the recommended starter order; the routing tools are designed to feed into the next layer of tools and into the right clinical guide or hub.

The mole risk screener is a triage aid that takes structured inputs about a mole — colour pattern, border quality, size change, recent change, and other established risk indicators — and produces an output that flags whether the presentation warrants prompt dermatology rather than routine scheduling. It is not a diagnostic tool; it cannot rule a mole in or out as suspicious. What it does well is help patients understand whether their mole is worth a prompt clinical examination versus a routine appointment, which protects against both over-anxiety on benign moles and under-prompt action on patterns that deserve faster review. The follow-up at the clinic is dermoscopy and clinical examination by the dermatologist.

Tools whose underlying scoring logic is Indian-skin-aware — such as several of the pigmentation and acne aids — are calibrated for Fitzpatrick III–V as default. Tools whose logic was developed against lighter Fitzpatrick populations (some imported severity scales, certain ageing-tool frameworks) are flagged for clinician supplementation; the framework prevents confidently-wrong outputs in melanin-rich skin. Patients should treat tool outputs as a starting picture and validate against clinician examination for decision-grade questions; the framework prioritises clinical accuracy over confident-but-miscalibrated output.

No. Tools route to clinical pathways but do not select treatment, do not select dose, and do not account for individual contraindications, medication history, or skin-pattern specifics that only a dermatologist examination identifies. Self-treating from tool outputs is not the framework the tools are built for; the consultation is where treatment decisions are made and where written plans with realistic ranges are produced. Patients who use tools to identify the right pathway and then book a consultation receive better, safer plans than patients who attempt to act on tool outputs alone.

No. Tool inputs at DDC are not stored against patient identity. The output a tool produces in a session belongs to the patient; the clinic does not maintain a database of inputs linked to identifiers. Patients who use the tools without account creation use them anonymously by default. Outputs can be saved by the patient if they wish to bring them to a consultation; the consultation does not require prior tool-use to begin and does not check for it. Privacy is the starting condition rather than an opt-in feature.

Tool outputs are a starting picture, not a verdict. A patient who disagrees with a tool output is in good company — outputs depend on inputs, and self-administered inputs sometimes underweight or overweight specific symptoms. The recommended next step is consultation, where examination and clinician judgement integrate alongside the tool output rather than being driven by it. Tools sometimes flag concerns the patient was not previously focused on; tools sometimes miss nuances the patient knows are important. Both patterns are normal, and the framework treats consultation as the integration step.

Skin tools at DDC are free, do not require account creation, and do not store inputs against patient identity. For any decision-grade skin question, the dermatologist consultation that starts from ₹1,999* is the appropriate next step beyond tool reading. The skin-tool layer routes the patient toward the right hub or guide; the visit itself is where examination integrates with history-taking and where the written plan with realistic ranges is produced. Skin tools are kept paywall-free at DDC and the framework deliberately positions the entire library as public-good education rather than as a lead-capture stage in a sales funnel.